Home Hospital Outcomes for Acute Decompensated Heart Failure and Factors Associated With Escalation of Care.
Aditya Achanta, Jason H Wasfy, Carson Tyler Moss...
https://pubmed.ncbi.nlm.nih.gov/38054286/Actively Recruiting
Led by Tel-Aviv Sourasky Medical Center · Updated on 2026-11-03
150
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the safety and effectiveness of hospital-level care provided at home compared to standard in-hospital care for adults with certain stable cardiovascular conditions. The trial focuses on patients admitted for issues such as acute myocardial infarction after uncomplicated procedures, pericarditis or myocarditis, pulmonary embolism, heart failure, valve replacement, or device implantation. This prospective, randomized controlled trial aims to understand if home-based care can improve patient experience while managing healthcare resources. Participants are randomly assigned to either continue standard hospital care or receive hospital-level care at home. Those in the home care group will have continuous remote monitoring of vital signs and heart rhythm, 247 access to a hospital monitoring center, daily nurse visits, and virtual cardiologist assessments. Additional tests, medications, oxygen therapy, and specialist consultations are provided at home as needed. An emergency pathway allows quick hospital transfer if necessary. During the study, participants will be monitored from admission until discharge, averaging 3 to 5 days, with safety outcomes tracked including mortality, infections, kidney injury, blood clots, medication errors, and readmissions within 30 days. Patient experience is measured by a detailed questionnaire at discharge. Secondary outcomes include length of stay, resource use, mobility, sleep, arrhythmias, and psychological health. The total study duration extends through hospitalization and 30 days post-discharge to assess these outcomes.
CONDITIONS
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
M
Michal Laufer Perl, MD, MHA
S
Shmuel Banai, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tel-Aviv Sourasky Medical Center
Lead Sponsor
SABAR HEALTH
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Average of 3 to 5 days
Participants receive either hospital-level care at home with remote monitoring, daily nurse visits, and virtual cardiologist assessments, or standard hospital care.
Daily visits and continuous monitoring
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aditya Achanta, Jason H Wasfy, Carson Tyler Moss...
https://pubmed.ncbi.nlm.nih.gov/38054286/David M Levine, Kei Ouchi, Bonnie Blanchfield...
https://pubmed.ncbi.nlm.nih.gov/31842232/David M Levine, Jeffrey Souza, Jeffrey L Schnipper...
https://pubmed.ncbi.nlm.nih.gov/38190713/Tel-Aviv Sourasky Medical Center
Lead Sponsor
SABAR HEALTH
Collaborating Sponsor